Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433439 | SCV000520263 | likely benign | not specified | 2018-01-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000865442 | SCV001006406 | benign | ALG1-congenital disorder of glycosylation | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532278 | SCV001747760 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ALG1: BP4, BP7, BS2 |
Fulgent Genetics, |
RCV000865442 | SCV002798362 | benign | ALG1-congenital disorder of glycosylation | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003912662 | SCV004739366 | likely benign | ALG1-related disorder | 2022-02-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV001532278 | SCV005217406 | likely benign | not provided | criteria provided, single submitter | not provided |